Learning Objectives

Learning objectives are in place for our heart failure in primary care event on Saturday, May 4th.

After this symposium, participants will be better able to:

    • Describe the underlying epidemiology and pathogenesis of heart failure
    • Identify those patients who are at higher risk of developing heart failure, including those with comorbidities, with an eye to disease prevention
    • Review where and when patients with heart failure come into contact with the health-care system and come to the attention of physicians
    • Employ the right imaging techniques and other specialized tools at the right time, in consult with a cardiologist
    • Recognize emerging issues in the management of heart failure, from cardiotoxicity to familial testing to new therapies expected in the coming decade

    Learning objectives specific to presentations (in chronological order):
     

    What is heart failure and how common is it?
    • Predict those patients who are most vulnerable to developing heart failure
    • Analyze the epidemiology of heart failure at any age
     Type 2 diabetes and kidney dysfunction: how to prevent heart failure
    • Describe how heart failure develops from type 2 diabetes and renal disease
    • Identify patients whose renal or diabetic condition puts them at higher risk of heart failure, as well as treatment options to consider
    How to manage diabetic and renal patients with CVD
    • Distinguish new drugs that prevent both renal failure and heart failure in this high-risk population as well as those that do not
    • Appraise therapeutic options that will safely manage patients whose cardiovascular conditions intersect with type 2 diabetes and renal dysfunction
    Heart failure care: from the emergency room to the doctor’s office
    • Recognize how patients with heart failure first present to the health-care system
    • Review how initial interactions, often in the emergency room, can inform prognosis as well as the role of family doctor and specialist in managing patients with heart failure
     Translating a cardiology consult
    • Define how a cardiology team can assist family doctors in managing their patients with heart failure
    • Recognize the right questions a family doctor must ask of a patient’s cardiology team as well as the conditions that would call for a referral to the cardiologist
    Is there an ECHO in here? Imaging in HF
    • Interpret when an ECHO is and is not needed, and apply any imaging report that is ordered
    • Discuss the differences between heart failure with preserved ejection fractions and heart failure with reduced ejection fractions
    Managing late-stage patients with HFrEF and HFpEF
    • Judge whether a patient with heart failure has entered late-stage disease
    • Discuss the role of the family doctor in managing heart failure with preserved or reduced ejection fractions
    Innovative therapies on the horizon
    • Describe coming medications and medical devices that are soon expected to impact heart failure management for the better
    • Discuss evolving trends in the use of health-care data and remote patient monitoring and what it will mean for patients with heart failure
    Caring for families with a heart failure diagnosis
    • Recognize how heart failure may extend through families and implement preventative strategies for undiagnosed members of a family
    • Review how common heart failure is in children, and recognize early symptoms that the heart’s function is compromised
    Genetic testing and the prevention of heart failure
    • Outline when, how and which genetic test to order for patients with heart failure
    • Interpret genetic test results and discuss clinical implications for the patient and family
    Cardiotoxicity: protecting the hearts of cancer patients
    • Describe the toxic impact to the heart from traditional forms of chemotherapy
    • Recognize the adverse cardiovascular risk associated with newer cancer treatments
    • Estimate the rare but serious cardiac toxicity associated with cancer immunotherapy